MedPath

PARACOR MEDICAL, INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial

Phase 2
Terminated
Conditions
Heart Failure
Interventions
Device: HeartNet Ventricular Support System
Drug: Optimal Medical/Device Therapy
First Posted Date
2006-10-02
Last Posted Date
2012-07-13
Lead Sponsor
Paracor Medical, Inc
Target Recruit Count
220
Registration Number
NCT00382863
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Alabama Birmingham, Birmingham, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

USC Keck School of Medicine, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, Medical Center, San Francisco, California, United States

and more 32 locations

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Phase 1
Terminated
Conditions
Heart Failure, Congestive
First Posted Date
2006-02-14
Last Posted Date
2012-05-21
Lead Sponsor
Paracor Medical, Inc
Target Recruit Count
39
Registration Number
NCT00291551
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Alabama at Birmingham, Division of Cardiovascular Disease, Birmingham, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado, Health Sciences Center, Denver, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Florida, Division of Cardiology, Gainesville, Florida, United States

and more 9 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.